BioGaia AB logo

BioGaia AB (BIOG.B)

Market Closed
XSTO XSTO
kr
kr
1.12B Market Cap
- P/E Ratio
2.54% Div Yield
- Volume
- Eps
kr
Previous Close
Day Range
0 0
Year Range
0 0
Want to track BIOG.B and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

BIOG.B is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSTO (SEK).

BIOG.B Chart

Similar

Stille AB
kr 185
-0.54%
Cereno Scientific AB
kr -
-
RUG
Rugvista Group AB
kr 69.6
+0.29%
Vertiseit AB
kr -
-
Bokusgruppen AB
kr 74.2
-1.59%

BioGaia AB (BIOG.B) FAQ

What is the stock price today?

The current price is kr0.00.

On which exchange is it traded?

BioGaia AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is BIOG.B.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 2.54%.

What is its market cap?

As of today, the market cap is 1.12B.

Has BioGaia AB ever had a stock split?

No, there has never been a stock split.

BioGaia AB Profile

Specialty Retail Industry
Consumer Discretionary Sector
Ms. Theresa P. Agnew CEO
XSTO Exchange
- ISIN
SE Country
224 Employees
- Last Dividend
18 May 2022 Last Split
- IPO Date

Overview

BioGaia AB (publ) is a globally recognized healthcare company specializing in the development and distribution of probiotic products. Established in 1990, the company has its headquarters in Stockholm, Sweden. It operates through three primary segments: Pediatrics, Adult Health, and Other. BioGaia has carved a niche for itself in the healthcare industry by focusing on delivering probiotic products that cater to different age groups and health needs. Its distribution network spans worldwide, leveraging both external partners and proprietary channels to reach a diverse customer base.

Products and Services

  • Pediatrics Segment:

    Under its Pediatrics segment, BioGaia offers a range of probiotic products aimed at improving children's health. This includes probiotic drops, which are designed to be easy to administer to infants and young children; oral rehydration solutions, which provide essential electrolytes lost during bouts of diarrhea; gut health tablets tailored for slightly older children; and specific cultures used as ingredients in infant formulas. These products are developed to support the digestive systems of babies and children, enhancing overall health and wellbeing.

  • Adult Health Segment:

    The Adult Health segment focuses on products for grown-ups, including gut health tablets that help maintain a healthy digestive system; oral health lozenges designed to support the oral microbiome; and specific probiotic cultures used in a licensee's dairy products. These offerings target common adult health concerns, particularly those related to gut and oral health, providing natural, probiotic-based solutions.

  • Other Segment:

    Aside from its core probiotic products, BioGaia also engages in the provision of packaging solutions. This segment serves to support the company's main operations as well as offering these services to the wider market. It underscores BioGaia's commitment to delivering not just health solutions but also supporting the lifecycle of its products from production to consumer.

Contact Information

Address: Kungsbroplan 3
Phone: 46 8 55 52 93 00